Riskpilot← Back to searchSign inGet full accessKIANAVA AB
ABActiveOrg 5590221262Gårdsvägen 20 AGeneral medical practice activities · NACE 8621Est. 20151 employees
Revenue 2024
SEK 839K
+25% vs 2023
EBITDA margin
33.9%
+23% vs 2023
Equity ratio
37.5%
Financial strength
Net profit 2024
SEK 174K
-20% vs 2023
| Revenue | SEK 839K | +25% |
| EBITDA | SEK 284K | +23% |
| Net profit | SEK 174K | -20% |
| Total assets | SEK 583K | +24% |
| Equity | SEK 219K | +131% |
| Employees | 1 | — |
Legal name
KIANAVA AB
Org number
5590221262
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
4 augusti 2015
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultverksamhet inom vården, inklusive primärvård, slutenvård samt friskvård, och därmed förenlig verksamhet och uppdrag. Konsultverksamhet med arbete inom mänskliga rättigheter, internationella relationer, kulturforskning samt utvecklingsarbete inom ramen för demokratiska processer.
Address
Gårdsvägen 20 A
Email
doctor.izadkhasti@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 143 | 202 | 140 | 671 | 839 |
| Staff expenses | — | — | — | −302 | −202 |
| EBITDA | −92 | −23 | −171 | 230 | 284 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | −92 | −23 | −171 | 230 | 284 |
| Net financials | −1 | −1 | — | −1 | −0 |
| Profit before tax | −92 | −23 | −172 | 229 | 219 |
| Tax | −0 | −0 | −0 | −13 | −45 |
| Net profit | −92 | −23 | −172 | 216 | 174 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 96 | 95 | 351 | 472 | 583 |
| Equity | 50 | 50 | 50 | 95 | 219 |
| Long-term debt | 0 | 0 | 0 | — | 50 |
| Short-term debt | 46 | 45 | 301 | 377 | 250 |
| Total debt | 46 | 45 | 301 | 377 | 299 |
EBITDA margin
33.9%
This company
15.8%
Market median
+115% vs market
20202024
Equity ratio
37.5%
This company
38.2%
Market median
+2% vs market
20202024
Return on equity
79.4%
This company
18.4%
Market median
+332% vs market
20202024
Net profit margin
20.7%
This company
8.1%
Market median
+156% vs market
20202024
Asset turnover
1.44×
This company
1.12×
Market median
+29% vs market
20202024
Debt / equity
1.66×
This company
0.62×
Market median
-168% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KIANAVA AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Monireh Shirani | Deputy Board Member | 0 companies |
| Kaveh Izadkhasti | Board of Directors | 0 companies |